Routine identification of medical fungi by the new vitek MS matrix-assisted laser desorption ionization - Time of flight system with a new time-effective strategy

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 2107-2110

  Iriart, Xavier ^a,b   Lavergne, Rose Anne ^a,b   Fillaux, Judith ^a,b   Valentin, Alexis ^a,b   Magnaval, Jean François ^a   Berry, Antoine ^a,b   Cassaing, Sophie ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b Université Paul Sabatier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; PYRROLE; RIBOSOME DNA;

ACCURACY; ALGORITHM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; CANDIDA; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INTERMETHOD COMPARISON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL;

FUNGI; HUMANS; MICROBIOLOGICAL TECHNIQUES; MYCOLOGY; MYCOSES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

ASPERGILLUS; FUNGI;

EID: 84862084348     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06713-11     Document Type: Article

References (20)

1. Alanio A, et al. 2011. Matrix-assisted laser desorption ionization timeof- flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin. Microbiol. Infect. 17:750-755.
2. Bader O, et al. 2011. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:1359-1365.
3. Borman AM, et al. 2008. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J. Clin. Microbiol. 46:933-938. (Pubitemid 351379982)
4. De Carolis E, et al. 27 July 2011, posting date. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix- assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2011.03599.x.
5. Denning DW, Kibbler CC, Barnes RA. 2003. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect. Dis. 3:230-240. (Pubitemid 36389186)
6. Desnos-Ollivier M, et al. 2008. Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii). J. Clin. Microbiol. 46:3237-3242.
7. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J. Clin. Microbiol. 49:1614-1616.
8. Garey KW, et al. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31. (Pubitemid 43939072)
9. Glass NL, Donaldson GC. 1995. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl. Environ. Microbiol. 61:1323-1330.
10. Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ. 2005. Assessment of ribosomal large-subunit D1-D2, internal transcribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species. J. Clin. Microbiol. 43:2092-2103. (Pubitemid 40656213)
11. Jensen RH, Arendrup MC. 2011. Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J. Clin. Microbiol. 49:549-556.
12. Kim S, et al. 2011. Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care. J. Korean Med. Sci. 26:297-300.
13. Kurtzman CP, Robnett CJ. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35:1216-1223. (Pubitemid 27175254)
14. Nolla-Salas J, et al. 1997. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med. 23:23-30. (Pubitemid 27067892)
15. Pappas PG, et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
16. Pinto A, et al. 2011. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One 6:e25712. doi:10.1371/journal.pone.0025712.
17. Qian J, Cutler JE, Cole RB, Cai Y. 2008. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal. Bioanal. Chem. 392:439-449.
18. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. 2010. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48:3482-3486.
19. Van Herendael BH, et al. 2012. Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Eur. J. Clin. Microbiol. Infect. Dis. 31:841-848.
20. van Veen SQ, Claas EC, Kuijper EJ. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48:900-907.